BIOFIL CHEMICALS & PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of BIOFIL CHEMICALS & PHARMACEUTICALS have increased by 34.19% YoY .
The Earnings Per Share (EPS) of BIOFIL CHEMICALS & PHARMACEUTICALS has decreased by -20.93 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
BIOFIL CHEMICALS & PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524396|NSE : BIOFILCHEM]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹30 Cr | ₹22 Cr | ₹36 Cr | ₹30 Cr | ₹23 Cr |
| Expenses | ₹29 Cr | ₹21 Cr | ₹34 Cr | ₹28 Cr | ₹22 Cr |
| Operating Profit (Excl OI) | ₹1.17 Cr | ₹1.33 Cr | ₹1.60 Cr | ₹1.82 Cr | ₹1.02 Cr |
| Other Income | ₹0.10 Cr | ₹0.15 Cr | ₹0.80 Cr | ₹0.17 Cr | ₹0.10 Cr |
| Interest | ₹0.04 Cr | ₹0.04 Cr | ₹0.07 Cr | ₹0.12 Cr | ₹0.16 Cr |
| Depreciation | ₹0.43 Cr | ₹0.43 Cr | ₹0.41 Cr | ₹0.41 Cr | ₹0.37 Cr |
| Profit Before Tax | ₹0.79 Cr | ₹1.02 Cr | ₹1.92 Cr | ₹1.46 Cr | ₹0.60 Cr |
| Profit After Tax | ₹0.56 Cr | ₹0.70 Cr | ₹1.24 Cr | ₹1.21 Cr | ₹0.48 Cr |
| Consolidated Net Profit | ₹0.56 Cr | ₹0.70 Cr | ₹1.24 Cr | ₹1.21 Cr | ₹0.48 Cr |
| Earnings Per Share (Rs) | ₹0.34 | ₹0.43 | ₹0.76 | ₹0.74 | ₹0.30 |
| PAT Margin (%) | 1.87 | 3.12 | 3.47 | 4.07 | 2.09 |
| ROE(%) | 3.28 | 4.24 | 8.01 | 8.46 | 3.60 |
| ROCE(%) | 4.76 | 6.23 | 12.18 | 10.12 | 5.06 |
| Total Debt/Equity(x) | 0.03 | 0.03 | 0.03 | 0.08 | 0.12 |
Key Financials |
||
| Market Cap | : | ₹ 118.4 Cr |
| Revenue (TTM) | : | ₹ 38.5 Cr |
| Net Profit(TTM) | : | ₹ 0.7 Cr |
| EPS (TTM) | : | ₹ 0.4 |
| P/E (TTM) | : | 177.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BIOFIL CHEMICALS & PHARMACEUTICALS | NA | NA | NA |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
BIOFIL CHEMICALS & PHARMACEUTICALS Revenues
[BOM: 524396|NSE : BIOFILCHEM]
| Y-o-Y | 34.19 % |
| 5 Yr CAGR | 6.75 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹30 Cr | 34.19 | |
| Mar2022 | ₹22 Cr | -37.39 | |
| Mar2021 | ₹36 Cr | 20.41 | |
| Mar2020 | ₹30 Cr | 28.37 | |
| Mar2019 | ₹23 Cr | - | |
BIOFIL CHEMICALS & PHARMACEUTICALS Operating Profit
[BOM: 524396|NSE : BIOFILCHEM]
| Y-o-Y | -12.38 % |
| 5 Yr CAGR | 3.34 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹1.17 Cr | -12.38 | |
| Mar2022 | ₹1.33 Cr | -16.64 | |
| Mar2021 | ₹1.60 Cr | -12.29 | |
| Mar2020 | ₹1.82 Cr | 78.03 | |
| Mar2019 | ₹1.02 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -34.73 % |
| 5 Yr CAGR | -3.20 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 3.89% | -34.73 | |
| Mar2022 | 5.96% | 33.33 | |
| Mar2021 | 4.47% | -27.20 | |
| Mar2020 | 6.14% | 38.60 | |
| Mar2019 | 4.43% | - | |
BIOFIL CHEMICALS & PHARMACEUTICALS Profit After Tax
[BOM: 524396|NSE : BIOFILCHEM]
| Y-o-Y | -19.77 % |
| 5 Yr CAGR | 3.82 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹0.56 Cr | -19.77 | |
| Mar2022 | ₹0.70 Cr | -43.76 | |
| Mar2021 | ₹1.24 Cr | 2.82 | |
| Mar2020 | ₹1.21 Cr | 150.41 | |
| Mar2019 | ₹0.48 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -40.06 % |
| 5 Yr CAGR | -2.74 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 1.87 % | -40.06 | |
| Mar2022 | 3.12 % | -10.09 | |
| Mar2021 | 3.47 % | -14.74 | |
| Mar2020 | 4.07 % | 94.74 | |
| Mar2019 | 2.09 % | - | |
BIOFIL CHEMICALS & PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524396|NSE : BIOFILCHEM]
| Y-o-Y | -20.93 % |
| 5 Yr CAGR | 3.18 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹0.34 | -20.93 | |
| Mar2022 | ₹0.43 | -43.42 | |
| Mar2021 | ₹0.76 | 2.70 | |
| Mar2020 | ₹0.74 | 146.67 | |
| Mar2019 | ₹0.30 | - | |
BIOFIL CHEMICALS & PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524396|NSE : BIOFILCHEM]
| Y-o-Y | -23.60 % |
| 5 Yr CAGR | -1.52 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 4.76% | -23.60 | |
| Mar2022 | 6.23% | -48.85 | |
| Mar2021 | 12.18% | 20.36 | |
| Mar2020 | 10.12% | 100.00 | |
| Mar2019 | 5.06% | - | |
BIOFIL CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹72.7 |
| Current MarketCap | : | ₹ 118.4 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOFIL CHEMICALS & PHARMACEUTICALS | NA | NA |
|
| SENSEX | 1.3% |
2.6% |
24% |
BIOFIL CHEMICALS & PHARMACEUTICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about BIOFIL CHEMICALS & PHARMACEUTICALS Financials
How the annual revenues of BIOFIL CHEMICALS & PHARMACEUTICALS have changed ?
The Revenues of BIOFIL CHEMICALS & PHARMACEUTICALS have increased by 34.19% YoY .
How the Earnings per Share (EPS) of BIOFIL CHEMICALS & PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of BIOFIL CHEMICALS & PHARMACEUTICALS has decreased by -20.93 % YoY .
Check out Intrinsic Value of Peers of BIOFIL CHEMICALS & PHARMACEUTICALS
Compare Stock Analytics of Peers of BIOFIL CHEMICALS & PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
